Life Tech Seeks Licensee for Therapeutic siRNA Delivery Technology

The technology is 100 times more potent that the company's current research-only transfection reagent, according to a Life Tech official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.